List of Tables
Table 1. Global Diagnostic Kit for Drugs of Abuses Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Diagnostic Kit for Drugs of Abuses Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Diagnostic Kit for Drugs of Abuses Market Competitive Situation by Manufacturers in 2024
Table 4. Global Diagnostic Kit for Drugs of Abuses Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Diagnostic Kit for Drugs of Abuses Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Diagnostic Kit for Drugs of Abuses Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Diagnostic Kit for Drugs of Abuses Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Diagnostic Kit for Drugs of Abuses, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diagnostic Kit for Drugs of Abuses, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diagnostic Kit for Drugs of Abuses, Product Type & Application
Table 12. Global Key Manufacturers of Diagnostic Kit for Drugs of Abuses, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diagnostic Kit for Drugs of Abuses by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Kit for Drugs of Abuses as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diagnostic Kit for Drugs of Abuses Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Diagnostic Kit for Drugs of Abuses Sales by Region (2020-2025) & (K Units)
Table 18. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Region (2020-2025)
Table 19. Global Diagnostic Kit for Drugs of Abuses Sales by Region (2026-2031) & (K Units)
Table 20. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Region (2026-2031)
Table 21. Global Diagnostic Kit for Drugs of Abuses Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Region (2020-2025)
Table 23. Global Diagnostic Kit for Drugs of Abuses Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Region (2026-2031)
Table 25. North America Diagnostic Kit for Drugs of Abuses Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Diagnostic Kit for Drugs of Abuses Sales by Country (2020-2025) & (K Units)
Table 27. North America Diagnostic Kit for Drugs of Abuses Sales by Country (2026-2031) & (K Units)
Table 28. North America Diagnostic Kit for Drugs of Abuses Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Diagnostic Kit for Drugs of Abuses Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Diagnostic Kit for Drugs of Abuses Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Diagnostic Kit for Drugs of Abuses Sales by Country (2020-2025) & (K Units)
Table 32. Europe Diagnostic Kit for Drugs of Abuses Sales by Country (2026-2031) & (K Units)
Table 33. Europe Diagnostic Kit for Drugs of Abuses Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Diagnostic Kit for Drugs of Abuses Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Diagnostic Kit for Drugs of Abuses Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Diagnostic Kit for Drugs of Abuses Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Diagnostic Kit for Drugs of Abuses Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Diagnostic Kit for Drugs of Abuses Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Diagnostic Kit for Drugs of Abuses Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diagnostic Kit for Drugs of Abuses Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Diagnostic Kit for Drugs of Abuses Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Diagnostic Kit for Drugs of Abuses Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Diagnostic Kit for Drugs of Abuses Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Diagnostic Kit for Drugs of Abuses Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Diagnostic Kit for Drugs of Abuses Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Diagnostic Kit for Drugs of Abuses Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Diagnostic Kit for Drugs of Abuses Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Diagnostic Kit for Drugs of Abuses Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Diagnostic Kit for Drugs of Abuses Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Diagnostic Kit for Drugs of Abuses Sales (K Units) by Type (2020-2025)
Table 51. Global Diagnostic Kit for Drugs of Abuses Sales (K Units) by Type (2026-2031)
Table 52. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Type (2020-2025)
Table 53. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Type (2026-2031)
Table 54. Global Diagnostic Kit for Drugs of Abuses Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Diagnostic Kit for Drugs of Abuses Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Type (2020-2025)
Table 57. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Type (2026-2031)
Table 58. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Type (2020-2025)
Table 59. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Type (2026-2031)
Table 60. Global Diagnostic Kit for Drugs of Abuses Sales (K Units) by Application (2020-2025)
Table 61. Global Diagnostic Kit for Drugs of Abuses Sales (K Units) by Application (2026-2031)
Table 62. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Application (2020-2025)
Table 63. Global Diagnostic Kit for Drugs of Abuses Sales Market Share by Application (2026-2031)
Table 64. Global Diagnostic Kit for Drugs of Abuses Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Diagnostic Kit for Drugs of Abuses Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Application (2020-2025)
Table 67. Global Diagnostic Kit for Drugs of Abuses Revenue Market Share by Application (2026-2031)
Table 68. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Application (2020-2025)
Table 69. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Diagnostic Kit for Drugs of Abuses Product
Table 74. Abbott Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche Diagnostic Kit for Drugs of Abuses Product
Table 79. Roche Recent Developments/Updates
Table 80. Thermo Scientific Company Information
Table 81. Thermo Scientific Description and Business Overview
Table 82. Thermo Scientific Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Scientific Diagnostic Kit for Drugs of Abuses Product
Table 84. Thermo Scientific Recent Developments/Updates
Table 85. NOVABIOS Company Information
Table 86. NOVABIOS Description and Business Overview
Table 87. NOVABIOS Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. NOVABIOS Diagnostic Kit for Drugs of Abuses Product
Table 89. NOVABIOS Recent Developments/Updates
Table 90. AdvaCare Pharma Company Information
Table 91. AdvaCare Pharma Description and Business Overview
Table 92. AdvaCare Pharma Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AdvaCare Pharma Diagnostic Kit for Drugs of Abuses Product
Table 94. AdvaCare Pharma Recent Developments/Updates
Table 95. Atlas Medical Company Information
Table 96. Atlas Medical Description and Business Overview
Table 97. Atlas Medical Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Atlas Medical Diagnostic Kit for Drugs of Abuses Product
Table 99. Atlas Medical Recent Developments/Updates
Table 100. Biopanda Reagents Company Information
Table 101. Biopanda Reagents Description and Business Overview
Table 102. Biopanda Reagents Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Biopanda Reagents Diagnostic Kit for Drugs of Abuses Product
Table 104. Biopanda Reagents Recent Developments/Updates
Table 105. JAL Medical and JAL Innovation Company Information
Table 106. JAL Medical and JAL Innovation Description and Business Overview
Table 107. JAL Medical and JAL Innovation Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. JAL Medical and JAL Innovation Diagnostic Kit for Drugs of Abuses Product
Table 109. JAL Medical and JAL Innovation Recent Developments/Updates
Table 110. Vitrosens Biotechnology Company Information
Table 111. Vitrosens Biotechnology Description and Business Overview
Table 112. Vitrosens Biotechnology Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Vitrosens Biotechnology Diagnostic Kit for Drugs of Abuses Product
Table 114. Vitrosens Biotechnology Recent Developments/Updates
Table 115. MP Biomedicals Company Information
Table 116. MP Biomedicals Description and Business Overview
Table 117. MP Biomedicals Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. MP Biomedicals Diagnostic Kit for Drugs of Abuses Product
Table 119. MP Biomedicals Recent Developments/Updates
Table 120. Bioeasy Biotechnology Company Information
Table 121. Bioeasy Biotechnology Description and Business Overview
Table 122. Bioeasy Biotechnology Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Bioeasy Biotechnology Diagnostic Kit for Drugs of Abuses Product
Table 124. Bioeasy Biotechnology Recent Developments/Updates
Table 125. InTec Company Information
Table 126. InTec Description and Business Overview
Table 127. InTec Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. InTec Diagnostic Kit for Drugs of Abuses Product
Table 129. InTec Recent Developments/Updates
Table 130. Xiamen Boson Biotech Company Information
Table 131. Xiamen Boson Biotech Description and Business Overview
Table 132. Xiamen Boson Biotech Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Xiamen Boson Biotech Diagnostic Kit for Drugs of Abuses Product
Table 134. Xiamen Boson Biotech Recent Developments/Updates
Table 135. Superbio Technology Company Information
Table 136. Superbio Technology Description and Business Overview
Table 137. Superbio Technology Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Superbio Technology Diagnostic Kit for Drugs of Abuses Product
Table 139. Superbio Technology Recent Developments/Updates
Table 140. Biotest Biotech Company Information
Table 141. Biotest Biotech Description and Business Overview
Table 142. Biotest Biotech Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Biotest Biotech Diagnostic Kit for Drugs of Abuses Product
Table 144. Biotest Biotech Recent Developments/Updates
Table 145. Alltest Biotech Company Information
Table 146. Alltest Biotech Description and Business Overview
Table 147. Alltest Biotech Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Alltest Biotech Diagnostic Kit for Drugs of Abuses Product
Table 149. Alltest Biotech Recent Developments/Updates
Table 150. Draeger Company Information
Table 151. Draeger Description and Business Overview
Table 152. Draeger Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Draeger Diagnostic Kit for Drugs of Abuses Product
Table 154. Draeger Recent Developments/Updates
Table 155. Orient Gene Biotech Company Information
Table 156. Orient Gene Biotech Description and Business Overview
Table 157. Orient Gene Biotech Diagnostic Kit for Drugs of Abuses Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Orient Gene Biotech Diagnostic Kit for Drugs of Abuses Product
Table 159. Orient Gene Biotech Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Diagnostic Kit for Drugs of Abuses Distributors List
Table 163. Diagnostic Kit for Drugs of Abuses Customers List
Table 164. Diagnostic Kit for Drugs of Abuses Market Trends
Table 165. Diagnostic Kit for Drugs of Abuses Market Drivers
Table 166. Diagnostic Kit for Drugs of Abuses Market Challenges
Table 167. Diagnostic Kit for Drugs of Abuses Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Diagnostic Kit for Drugs of Abuses
Figure 2. Global Diagnostic Kit for Drugs of Abuses Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diagnostic Kit for Drugs of Abuses Market Share by Type: 2024 & 2031
Figure 4. Urine Test Product Picture
Figure 5. Saliva Testing Product Picture
Figure 6. Blood Test Product Picture
Figure 7. Global Diagnostic Kit for Drugs of Abuses Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Diagnostic Kit for Drugs of Abuses Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Household
Figure 12. Global Diagnostic Kit for Drugs of Abuses Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Diagnostic Kit for Drugs of Abuses Market Size (2020-2031) & (US$ Million)
Figure 14. Global Diagnostic Kit for Drugs of Abuses Sales (2020-2031) & (K Units)
Figure 15. Global Diagnostic Kit for Drugs of Abuses Average Price (US$/Unit) & (2020-2031)
Figure 16. Diagnostic Kit for Drugs of Abuses Report Years Considered
Figure 17. Diagnostic Kit for Drugs of Abuses Sales Share by Manufacturers in 2024
Figure 18. Global Diagnostic Kit for Drugs of Abuses Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Diagnostic Kit for Drugs of Abuses Players: Market Share by Revenue in Diagnostic Kit for Drugs of Abuses in 2024
Figure 20. Diagnostic Kit for Drugs of Abuses Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Diagnostic Kit for Drugs of Abuses Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Diagnostic Kit for Drugs of Abuses Sales Market Share by Country (2020-2031)
Figure 23. North America Diagnostic Kit for Drugs of Abuses Revenue Market Share by Country (2020-2031)
Figure 24. United States Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Diagnostic Kit for Drugs of Abuses Sales Market Share by Country (2020-2031)
Figure 27. Europe Diagnostic Kit for Drugs of Abuses Revenue Market Share by Country (2020-2031)
Figure 28. Germany Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Diagnostic Kit for Drugs of Abuses Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Diagnostic Kit for Drugs of Abuses Revenue Market Share by Region (2020-2031)
Figure 35. China Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Diagnostic Kit for Drugs of Abuses Sales Market Share by Country (2020-2031)
Figure 43. Latin America Diagnostic Kit for Drugs of Abuses Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Diagnostic Kit for Drugs of Abuses Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Diagnostic Kit for Drugs of Abuses Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Diagnostic Kit for Drugs of Abuses Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Diagnostic Kit for Drugs of Abuses by Type (2020-2031)
Figure 54. Global Revenue Market Share of Diagnostic Kit for Drugs of Abuses by Type (2020-2031)
Figure 55. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Diagnostic Kit for Drugs of Abuses by Application (2020-2031)
Figure 57. Global Revenue Market Share of Diagnostic Kit for Drugs of Abuses by Application (2020-2031)
Figure 58. Global Diagnostic Kit for Drugs of Abuses Price (US$/Unit) by Application (2020-2031)
Figure 59. Diagnostic Kit for Drugs of Abuses Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
